We have seen 44 institutional investors add shares of $CCAP stock to their portfolio, and 44 decrease their positions in their most recent quarter.

Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) had its price objective hoisted by equities research analysts at Wells Fargo & Company from $18.00 to $19.00 in a research report issued on ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

CCAP experienced a stock price drop of over 10% due to uncertainty about its income potential and value proposition. CCAP's portfolio is 90% first-lien debt, with 85% in non-cyclical industries, ...

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) have received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, ...

Crescent Capital BDC, Inc. faces an 18% YTD stock price drop, and it left its investors wondering whether it's time to sell or buy more. CCAP's floating-rate debt portfolio makes it highly sensitive ...